305 related articles for article (PubMed ID: 10488700)
21. Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction.
Boland ML; Oldham S; Boland BB; Will S; Lapointe JM; Guionaud S; Rhodes CJ; Trevaskis JL
World J Gastroenterol; 2018 Apr; 24(16):1748-1765. PubMed ID: 29713129
[TBL] [Abstract][Full Text] [Related]
22. Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS).
Hossain N; Stepanova M; Afendy A; Nader F; Younossi Y; Rafiq N; Goodman Z; Younossi ZM
Scand J Gastroenterol; 2011 Apr; 46(4):479-84. PubMed ID: 21114431
[TBL] [Abstract][Full Text] [Related]
23. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA
Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180
[TBL] [Abstract][Full Text] [Related]
24. [Gene expression in obese patients with non-alcoholic steatohepatitis].
Cayón A; Crespo J; Guerra AR; Pons-Romero F
Rev Esp Enferm Dig; 2008 Apr; 100(4):212-8. PubMed ID: 18563978
[TBL] [Abstract][Full Text] [Related]
25. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Ito S; Yukawa T; Uetake S; Yamauchi M
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
[TBL] [Abstract][Full Text] [Related]
26. ASH and NASH.
Scaglioni F; Ciccia S; Marino M; Bedogni G; Bellentani S
Dig Dis; 2011; 29(2):202-10. PubMed ID: 21734385
[TBL] [Abstract][Full Text] [Related]
27. Pro-Inflammatory CXCR3 Impairs Mitochondrial Function in Experimental Non-Alcoholic Steatohepatitis.
Du J; Zhang X; Han J; Man K; Zhang Y; Chu ES; Nan Y; Yu J
Theranostics; 2017; 7(17):4192-4203. PubMed ID: 29158819
[TBL] [Abstract][Full Text] [Related]
28. Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis.
Portincasa P; Grattagliano I; Lauterburg BH; Palmieri VO; Palasciano G; Stellaard F
Clin Sci (Lond); 2006 Aug; 111(2):135-43. PubMed ID: 16603025
[TBL] [Abstract][Full Text] [Related]
29. Ultrastructural morphogenesis of mitochondria in alcoholic liver.
Chang ES
Acta Pathol Jpn; 1987 Feb; 37(2):213-24. PubMed ID: 3604676
[TBL] [Abstract][Full Text] [Related]
30. Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy.
Ingiliz P; Valantin MA; Duvivier C; Medja F; Dominguez S; Charlotte F; Tubiana R; Poynard T; Katlama C; Lombès A; Benhamou Y
Hepatology; 2009 Feb; 49(2):436-42. PubMed ID: 19085967
[TBL] [Abstract][Full Text] [Related]
31. Protein profiling and functional analysis of liver mitochondria from rats with nonalcoholic steatohepatitis.
You Y; Zhang Y; Lu Y; Hu K; Qu X; Liu Y; Lu B; Jin L
Mol Med Rep; 2017 Sep; 16(3):2379-2388. PubMed ID: 28677739
[TBL] [Abstract][Full Text] [Related]
32. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis.
Bonkovsky HL; Jawaid Q; Tortorelli K; LeClair P; Cobb J; Lambrecht RW; Banner BF
J Hepatol; 1999 Sep; 31(3):421-9. PubMed ID: 10488699
[TBL] [Abstract][Full Text] [Related]
33. PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis.
Mukhopadhyay P; Horváth B; Rajesh M; Varga ZV; Gariani K; Ryu D; Cao Z; Holovac E; Park O; Zhou Z; Xu MJ; Wang W; Godlewski G; Paloczi J; Nemeth BT; Persidsky Y; Liaudet L; Haskó G; Bai P; Boulares AH; Auwerx J; Gao B; Pacher P
J Hepatol; 2017 Mar; 66(3):589-600. PubMed ID: 27984176
[TBL] [Abstract][Full Text] [Related]
34. Clinical and pathological differences between alcoholic hepatitis and non-alcoholic steatohepatitis.
Sugimoto M; Sadamoto T; Nonaka H
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Feb; 38(1):34-45. PubMed ID: 12687723
[TBL] [Abstract][Full Text] [Related]
35. Giant mitochondria in human liver disease.
Shami GJ; Samarska IV; Koek GH; Li A; Palma E; Chokshi S; Wisse E; Braet F
Liver Int; 2023 Nov; 43(11):2365-2378. PubMed ID: 37615254
[TBL] [Abstract][Full Text] [Related]
36. Peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms in nonalcoholic fatty liver disease: a study in Brazilian patients.
Domenici FA; Brochado MJ; Martinelli Ade L; Zucoloto S; da Cunha SF; Vannucchi H
Gene; 2013 Oct; 529(2):326-31. PubMed ID: 23891824
[TBL] [Abstract][Full Text] [Related]
37. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C
Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117
[TBL] [Abstract][Full Text] [Related]
38. Useful parameters for distinguishing nonalcoholic steatohepatitis with mild steatosis from cryptogenic chronic hepatitis in the Japanese population.
Tanaka N; Tanaka E; Sheena Y; Komatsu M; Okiyama W; Misawa N; Muto H; Umemura T; Ichijo T; Matsumoto A; Yoshizawa K; Horiuchi A; Kiyosawa K
Liver Int; 2006 Oct; 26(8):956-63. PubMed ID: 16953836
[TBL] [Abstract][Full Text] [Related]
39. Hepatic mitochondrial DNA deletion in alcoholics: association with microvesicular steatosis.
Fromenty B; Grimbert S; Mansouri A; Beaugrand M; Erlinger S; Rötig A; Pessayre D
Gastroenterology; 1995 Jan; 108(1):193-200. PubMed ID: 7806041
[TBL] [Abstract][Full Text] [Related]
40. Association of PNPLA3 Polymorphism with Hepatocellular Carcinoma Development and Prognosis in Viral and Non-Viral Chronic Liver Diseases.
Khlaiphuengsin A; Kiatbumrung R; Payungporn S; Pinjaroen N; Tangkijvanich P
Asian Pac J Cancer Prev; 2015; 16(18):8377-82. PubMed ID: 26745088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
